Zai Lab Announces Presentations at June Conferences
SHANGHAI and SAN FRANCISCO, May 27, 2020 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab”) (NASDAQ: ZLAB), an innovative commercial-stage biopharmaceutical company, today announced that the Company will be presenting at the following upcoming virtual conferences in June. Details of the virtual conferences are as follows:
Jefferies Global Healthcare Conference 2020
Presentation: Tuesday, June 2, 2020 at 3:00 p.m. EDT
Presenter: Dr. Samantha Du, Founder, Chairperson & Chief Executive Officer
Goldman Sachs 41st Annual Global Healthcare Conference
Presentation: Thursday, June 11, 2020 at 9:40 a.m. EDT
Presenter: Dr. Samantha Du, Founder, Chairperson & Chief Executive Officer
JP Morgan China Investor Conference
Panel Discussion: Wednesday, June 24, 2020 at 8:00 a.m. CST
Presenter: Dr. Samantha Du, Founder, Chairperson & Chief Executive Officer
Live webcasts of the conferences will be available under "Events & Presentations” in the “Investors Relations” section of Zai Lab’s website. Archived replays will be available for 90 days following the event.
About Zai Lab
Zai Lab (NASDAQ:ZLAB) is an innovative commercial stage biopharmaceutical company focused on bringing transformative medicines for cancer, infectious and autoimmune diseases to patients in China and around the world. To quickly target the large, fast-growing segments of China’s pharmaceutical market and address unmet medical needs, Zai Lab’s experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates. Zai Lab has also built an in-house team with strong drug discovery and translational research capabilities, aiming to establish a global pipeline of proprietary drug candidates against targets in our focus areas. Zai Lab’s vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its portfolio in order to impact human health worldwide.
For additional information about the company, please visit or follow us at .
For more information, please contact:
ZAI LAB CONTACTS:
Zai Lab
Billy Cho, CFO
01
Media: Ryo Imai / Robert Flamm, Ph.D.
Burns McClellan, on behalf of Zai Lab
212-213-0006 ext. 315 / 364
/
Investors: Pete Rahmer / Mike Zanoni
Endurance Advisors, on behalf of Zai Lab
415-515-9763 / 610-442-8570
/